|Bid||66.88 x 900|
|Ask||66.91 x 800|
|Day's Range||65.75 - 67.57|
|52 Week Range||51.88 - 99.90|
|Beta (3Y Monthly)||0.68|
|PE Ratio (TTM)||124.74|
|Earnings Date||Jul 25, 2019 - Jul 29, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||76.75|
Magellan Health Inc NASDAQ/NGS:MGLNView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for MGLN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold MGLN had net inflows of $1.02 billion over the last one-month. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (MGLN), has launched an innovative solution to control spend for high-cost infusible drugs, while promoting high quality care for members. Payers are often faced with challenges like limited vial size options and availability that can lead to excessive spend in categories such as oncology and autoimmune conditions. The Magellan Rx drug wastage program leverages prior authorization and dosing protocols, in collaboration with providers, to identify clinically-appropriate opportunities to reduce waste.
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 9 percentage points since the end of the third quarter of 2018 as investors worried over the possible ramifications of rising interest rates and escalation of the trade war with China. The hedge funds and institutional investors we track typically invest more […]
Molina Healthcare (MOH) and Magellan Health (MGLN) are poised to grow in the expanding health insurance industry. Here we try to figure out which stock is positioned better.
Magellan Rx Management, the pharmacy benefit management division of Magellan Health, Inc. , today announced the launch of a medical pharmacy solution targeting oncology therapeutic biosimilars.
Magellan Health (MGLN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Magellan will provide free, confidential counseling services and other resources, such as tip sheets about trauma and how to process it, resiliency after such situations, and how to talk about these situations with children who may be following the news in the media.
Despite regulatory noise, strong fundamentals and changing demographics of the country poise health insurance stocks for growth.
Counseling and resources available free-of-charge to local community
Barry Smith became the CEO of Magellan Health, Inc. (NASDAQ:MGLN) in 2013. This analysis aims first to contrast CEO...
Unique report provides current and forward-looking pharmacy trends and cost management strategies for 2020 and beyond
Engaged Capital is a hedge fund that was founded in 2012 by Glenn W. Wellin, who previously sharpened his investment skills at famous Relational Investors where he was a Principal and Managing Director. The fund was launched with an initial capital of $85 million, and it has grown big since – holding $796.16 million in […]
The company is gearing up for its pivotal annual shareholders' meeting in June at which four nominees put forth from an activist investor hedge fund are looking to join the board.
Magellan Health (MGLN) delivered earnings and revenue surprises of -27.27% and 0.05%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Scottsdale, Arizona-based company said it had profit of 2 cents. Earnings, adjusted for one-time gains and costs, were 40 cents per share. The results fell short of Wall Street ...